Cancer Control and Prevention Protocols
Lung, Lung - Non-Small Cell, Lung - Non-Small Cell Metastatic
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer (Adenocarcinoma)
Eligible for screening study DCP 001
A221504 is unlikely to meet accrual goal. Therefore, it is permanently closed to accrual effective 06/30/20.